- Tytuł:
- A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study.
- Autorzy:
- Temat:
-
ANDROGENS
PROSTATE cancer
VASCULAR endothelial growth factor receptors
DRUG toxicity
NONCOMPLIANCE - Źródło:
- Prostate Cancer & Prostatic Diseases; 2012, Vol. 15 Issue 1, p87-92, 6p
Czasopismo naukowe